DURECT and Charles River input settlement for alzet in U.S., Canada (NASDAQ:DRRX)
- DURECT Company (NASDAQ:DRRX) entered right into a co-marketing and collaboration settlement with Charles River Laboratories for the alzet Osmotic Pumps Portfolio and Related Product Line within the U.S. and Canada.
- Each corporations will collectively marketplace and commercialize the alzet product line to consumers over a multi-year length.
- Charles River RMS will supply devoted advertising and marketing sources and collaborate with DURECT to expand and roll out a large vary of gross sales and advertising and marketing tasks for alzet.
- DURECT will stay accountable for production, advertising and marketing improve, order achievement and buyer billing.
- Supply: Press Unencumber
